NEURONETICS
Neuronetics is focused on developing non-invasive therapies for psychiatric and neurological disorders using MRI-strength magnetic field pulses. They are the first and only company to have a non-systemic and non-invasive depression treatment cleared by the FDA for patients who have not benefited from prior antidepressant treatment.
NEURONETICS
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2003-01-01
Address:
Malvern, Pennsylvania, United States
Country:
United States
Website Url:
http://www.neurostar.com
Total Employee:
101+
Status:
Active
Contact:
877-600-7555
Email Addresses:
[email protected]
Total Funding:
313.4 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Agenus
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cadent Therapeutics
Cadent Therapeutics develops novel medicines that tune and modulate brain rhythms for patients with serious neurological disease.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Photometics
Photometics develops infrared light-based therapy for skin cancer.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Spero Therapeutics
Spero Therapeutics is developing first in class therapeutics for treatment of gram-negative infections.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
J Carlo Cannell
J Carlo Cannell investment in Post-IPO Equity - Neuronetics
Solar capital
Solar capital investment in Post-IPO Debt - Neuronetics
Investor Growth Capital Limited
Investor Growth Capital Limited investment in Series G - Neuronetics
New Leaf Venture Partners
New Leaf Venture Partners investment in Series G - Neuronetics
Accuitive Medical Ventures
Accuitive Medical Ventures investment in Series G - Neuronetics
Industry Ventures
Industry Ventures investment in Series G - Neuronetics
ONSET Ventures
ONSET Ventures investment in Series G - Neuronetics
GE Ventures
GE Ventures investment in Series G - Neuronetics
KBL Healthcare Ventures
KBL Healthcare Ventures investment in Series G - Neuronetics
Pfizer Venture Investments
Pfizer Venture Investments investment in Series G - Neuronetics
Official Site Inspections
http://www.neurostar.com Semrush global rank: 686.07 K Semrush visits lastest month: 61.79 K
- Host name: 64.91.240.150
- IP address: 64.91.240.150
- Location: Lansing United States
- Latitude: 42.7348
- Longitude: -84.6245
- Metro Code: 551
- Timezone: America/Detroit
- Postal: 48917